Zhejiang Xinguang Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 44.77%

Zhejiang Xinguang Pharmaceutical Co Ltd (300519) has an Asset Resilience Ratio of 44.77% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Zhejiang Xinguang Pharmaceutical Co Ltd (300519) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥400.00 Million

≈ $58.53 Million USD Cash + Short-term Investments

Total Assets

CN¥893.41 Million

≈ $130.73 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Zhejiang Xinguang Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See Zhejiang Xinguang Pharmaceutical Co Ltd shareholders equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Xinguang Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300519 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥400.00 Million	44.77%
Total Liquid Assets	CN¥400.00 Million	44.77%

Asset Resilience Insights

Very High Liquidity: Zhejiang Xinguang Pharmaceutical Co Ltd maintains exceptional liquid asset reserves at 44.77% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Zhejiang Xinguang Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang Xinguang Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Yabao Pharmaceutical Group Co Ltd SHG:600351	Drug Manufacturers - Specialty & Generic	0.27%
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	6.43%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	6.40%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%

Annual Asset Resilience Ratio for Zhejiang Xinguang Pharmaceutical Co Ltd (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Zhejiang Xinguang Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	20.33%	CN¥185.00 Million ≈ $27.07 Million	CN¥909.78 Million ≈ $133.13 Million	+3.68pp
2023-12-31	16.66%	CN¥155.00 Million ≈ $22.68 Million	CN¥930.41 Million ≈ $136.15 Million	+4.65pp
2022-12-31	12.01%	CN¥115.00 Million ≈ $16.83 Million	CN¥957.76 Million ≈ $140.15 Million	-1.40pp
2021-12-31	13.41%	CN¥125.00 Million ≈ $18.29 Million	CN¥932.40 Million ≈ $136.44 Million	+3.86pp
2020-12-31	9.54%	CN¥85.00 Million ≈ $12.44 Million	CN¥890.79 Million ≈ $130.35 Million	-15.77pp
2019-12-31	25.32%	CN¥218.00 Million ≈ $31.90 Million	CN¥861.13 Million ≈ $126.01 Million	+3.67pp
2018-12-31	21.64%	CN¥178.00 Million ≈ $26.05 Million	CN¥822.50 Million ≈ $120.36 Million	-0.03pp
2017-12-31	21.68%	CN¥168.00 Million ≈ $24.58 Million	CN¥775.05 Million ≈ $113.41 Million	+0.28pp
2016-12-31	21.40%	CN¥150.00 Million ≈ $21.95 Million	CN¥700.95 Million ≈ $102.57 Million	--

pp = percentage points

About Zhejiang Xinguang Pharmaceutical Co Ltd

SHE:300519 China Drug Manufacturers - Specialty & Generic

Market Cap

$381.87 Million

CN¥2.61 Billion CNY

Market Cap Rank

#13908 Global

#4373 in China

Share Price

CN¥16.31

Change (1 day)

+0.74%

52-Week Range

CN¥13.84 - CN¥20.05

All Time High

CN¥52.02